Tech Talk: Biogen, Apple to tackle cognitive impairment

Biotech company Biogen, in collaboration with Apple, will be launching a study to to identify digital biomarkers to help monitor cognitive performance and health, including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as Alzheimer's disease As readers are likely to know, cognitive health - the ability to think clearly, to learn and to remember - is an indicator of brain health and important to performing daily activities. This collaborative study is the beginning of a trend that is bound to increase going forward.